domenica, Luglio 21, 2024
HomeAree tematicheDieta e capelliL-Lysina e trattamento della calvizie

L-Lysina e trattamento della calvizie


L-LYSINE AND THE TREATMENT OF HAIR LOSS US Patent 6136860 Applicant: Bio-Scientific Ltd., London, UK

An English biotech company was recently issued a US patent for the use of L-Lysine in the treatment of various types of hair loss, including androgenic alopecia. <BR< growth.?
“Typically, the L-lysine is administered in a daily dose of from 200 to 2000 mg, and more usually in a daily dose of 500 to 1500 mg, e.g. in the form of a 500 mg dose administered orally once, twice or three times a day.
L-lysine may conveniently be administered orally, for example as tablets, capsules.”

“We have also discovered that administration of lysine to patients results in a dramatic increase in the efficacy of known treatments for genetic hair loss (which term covers a number of conditions variously referred to as androgen-dependent alopecia, androgenic alopecia, androgenetic alopecia, common baldness, female baldness, diffuse hair loss and male pattern baldness).”
“Thus, in a further aspect of the present invention there is provided a kit including a plurality of separate containers, each containing at least one active agent useful in a combination therapy for the treatment of genetic hair loss, wherein said kit includes L-lysine and at least one further active agent selected from minoxidil, anti-androgens, 5.alpha.-reductase inhibitors, aromatase inhibitors.”
“The co-administration of L-lysine with known treatments for genetic hair loss such as minoxidil and anti-androgens results in a significant improvement in the efficacy of the treatment.”

[Numero Voti: 0 Media: 0]
La redazione di è formata da medici, specialisti e appassionati al tema della tricologia. Dal 1999, ci dedichiamo a diffondere informazioni sempre aggiornate sulla cultura della salute dei capelli.
Da leggere
Notizie correlate


Please enter your comment!
Please enter your name here

The reCAPTCHA verification period has expired. Please reload the page.